| 名稱 | C5aR1/CHO GPCR細(xì)胞 |
| 型號(hào) | CBP71374 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | C5aR1/CHO |
產(chǎn)品搜索
相關(guān)文章
- 腫瘤細(xì)胞的生長受哪些因素的作用呢？
- 人類白細(xì)胞抗原（HLA）基因分型檢測試劑注冊審查指導(dǎo)原則（2026年第2號(hào)）
- 靶向claudin18.2藥物細(xì)胞篩選模型
- 購買細(xì)胞株前需要了解的相關(guān)技術(shù)知識(shí)
- ATCC細(xì)胞的貼壁過程有何特點(diǎn)呢？
- BTK細(xì)胞篩選模型
- IHC第三方質(zhì)控品——病理質(zhì)控基石，精準(zhǔn)診斷起點(diǎn)
- 抑制性檢查點(diǎn)靶點(diǎn)及其細(xì)胞篩選模型
- 科學(xué)家有望利用對療法敏感性的癌細(xì)胞來清除耐藥性癌細(xì)胞
- BCMA靶點(diǎn)藥物細(xì)胞篩選模型
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > GPCR細(xì)胞株 > CBP71374C5aR1/CHO GPCR細(xì)胞
- 詳細(xì)內(nèi)容
| CBP71374 | |
| I. Background | |
| C5AR1 (Complement C5a Receptor 1) is a Protein Coding gene. Diseases associated with C5AR1 include Hypersensitivity Reaction Type Iii Disease and Mast-Cell Sarcoma. Among its related pathways are Complement cascade and GPCR downstream signalling. | |
| II. Introduction | |
| Host Cell: | CHO |
| Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS+5ug/ml puromycin |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen immediately upon delivery |
| Application(s): | Functional assay for C5aR1 receptor |
| Transducer: | Gi |
| Ⅲ. Description of Host Cell Line | |
| Organism: | Hamster |
| Tissue: | Ovary |
| Morphology: | Epithelial |
| Growth Properties: | Adherent |
| Ⅳ. Representative Data | |
Figure 1. Recombinant C5aR1/CHO constitutively expressing C5aR1. | |
Figure 2. HTRF cAMP Assay With C5aR1 CHO Cells (C7). | |
![CBP71374 數(shù)據(jù)圖 J[DYN3BO683Q([69DRJ]8BL.jpg](https://img69.chem17.com/gxhpic_a89b1029a6/1b082722e7f6039ba5d44ff07debfa891f13167810e206892a50a0eb93088f4927c7a7f4ad71fb85.jpg "CBP71374 數(shù)據(jù)圖 J[DYN3BO683Q([69DRJ]8BL.jpg")
會(huì)員_a.png)